ClinicalTrials.Veeva

Menu

Comparison of the Functional Walking Outcomes of Two Settings of a Commercially Available AFO in Adult Stroke Patients

A

Albert Einstein Healthcare Network

Status

Completed

Conditions

Walking Aided by a Leg Brace in Stroke Subjects

Treatments

Device: ADR™ brace resistance
Device: Conventional brace resistance (using hard stops)

Study type

Interventional

Funder types

Other

Identifiers

NCT02122783
HN 4422

Details and patient eligibility

About

The purpose of this study is to evaluate how two different settings of a commercially available ankle foot brace affect how stroke patients walk. The study brace is an ankle foot orthosis (AFO) that makes use of a newer type of joint that contains a soft insert, in addition to the conventional hard stops, to limit the range of motion of the ankle during walking. The results of this study will help to clarify 1) whether and how this new joint affects the way you walk, 2) whether it makes it easier for the clinician to align your brace and 3) your opinions about the new joint.

Full description

The purpose of this study is to evaluate how two different settings of a commercially available ankle foot brace affect how stroke patients walk. The study brace is an ankle foot orthosis (AFO) that makes use of a newer type of joint that contains a soft insert, in addition to the conventional hard stops, to limit the range of motion of the ankle during walking. Participants undergo testing in the gaitlab after using the new brace for a period of time. The results of this study will help to clarify 1) whether and how this new joint affects the way you walk, 2) whether it makes it easier for the clinician to align your brace and 3) your opinions about the new joint.

Enrollment

5 patients

Sex

All

Ages

21 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Between the ages of 21 and 70 males and non-pregnant females
  2. Diagnosis of stroke more than 1 year ago
  3. Ambulatory at 0.5m/s or greater
  4. Require unilateral AFOs to ambulate
  5. Stable medical condition - no concomitant progressive diseases that could affect motor function
  6. Ability to comply with directions and cooperate with research team

Exclusion criteria

  1. Subjects who are currently receiving physical therapy for gait problems
  2. Anticipated surgical or pharmacologic intervention for tone/contractures during the study period
  3. Additional neurologic or musculoskeletal diagnoses that might impair gait (i.e., recent orthopedic interventions (6 weeks), unhealed fractures, significant degenerative joint disease, lower limb amputation, uncontrolled seizures)
  4. Recent cardiac or active pulmonary disease, liable blood pressure
  5. Recent back surgery

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

5 participants in 2 patient groups

Conventional then Experimental brace resistance
Experimental group
Description:
Participants received the Default intervention for a period of a month, were evaluated in the lab and then the novel intervention was administered for use for the next month. There was a small period (few hours in the lab) where the subject was transitioned to the second intervention.
Treatment:
Device: Conventional brace resistance (using hard stops)
Device: ADR™ brace resistance
Experimental then Conventional brace resistance
Experimental group
Description:
Participants received the the novel elastomer to provide brace support intervention for a period of a month, were evaluated in the lab and then the conventional intervention was administered for use for the next month. There was a small period (few hours in the lab) where the subject was transitioned to the second intervention.
Treatment:
Device: Conventional brace resistance (using hard stops)
Device: ADR™ brace resistance

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems